1. A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers;Blode;Eur. J. Contracept. Reprod. Health Care,2000
2. A new monophasic oral contraceptive containing drospirenone. Effect on premenopausal symptoms;Brown;J. Reprod. Med.,2002
3. Crane, M.G., Harris, J.J., 1974a. Effect of estrogens and gestagens on the renin–angiotensin–aldosterone system and on plasma transcortin in women and men. In: Fregly, M.J., Fregly, M.S. (Eds.), Oral Contraceptives and High Blood Pressure. Dolphin Press, Gainesville, pp. 100–119.
4. Crane, M.G., Harris, J.J., 1974b. Effect of estrogens and gestagens on exchangeable sodium. In: Fregly, M.J., Fregly, M.S. (Eds.), Oral Contraceptives and High Blood Pressure. Dolphin Press, Gainesville, pp. 159–168.
5. The contraceptive profile of a new oral contraceptive with antimineralocorticoid and antiandrogenic effects;Foidart;Eur. J. Contracept. Reprod. Health Care,2000